Glenmark Pharmaceuticals Q4 Results: Net loss widens to ₹1,238.6 crore, revenue up 2% YoY; dividend declared | Company Business News - Mint
Glenmark Pharmaceuticals Q4 Results: The pharma major's revenue from operations in the fourth quarter of FY24 rose two per cent to ₹3,063 crore